Foxx Held Stock in Opioid and Coal Companies
The North Carolina representative held investments in firms while overseeing workforce policy.
Updated on Oct. 7, 2026 in Public Companies
Live Poll
Should members of Congress be prohibited from owning stocks in industries they regulate?
Representative Virginia Foxx disclosed holdings in pharmaceutical and coal companies as of May 2025. Her financial portfolio coincided with her tenure chairing the House Education and Workforce Committee.
Why it matters
The disclosures raise questions about potential conflicts of interest regarding Foxx's legislative actions on workplace safety and industry regulations. Her policy positions often aligned with industries in which she held financial stakes.
Foxx reported holding up to $100,000 in Alliance Resource Partners and $50,000 in AbbVie stock, while receiving over $93,000 in career industry donations. The Mountain View Mine, linked to her coal holdings, faced 827 safety penalties since 2019.
The players
Virginia Foxx
She is a member of the U.S. House of Representatives from North Carolina who chaired the House Education and Workforce Committee.
Alliance Resource Partners
This is a coal production company that has accrued over 900 workplace safety penalties since 2000.
AbbVie
This is a research-based pharmaceutical company that has been a significant player in the opioid market.
Mine Safety and Health Administration
This federal agency is responsible for enforcing safety and health regulations in the mining industry.
The details
Foxx executed 20 transactions totaling approximately $209,000 in Alliance Resource Partners stock. As committee chair, she opposed federal silica exposure rules, which industry groups estimated would cost $162 million in compliance expenses.
Timeline
Alliance Resource Partners began accruing safety penalties in 2000.
Mountain View Mine started receiving MSHA penalties in 2019.
Allergan finalized a $2.37 billion opioid settlement with North Carolina in 2022.
A federal silica protection rule was finalized in April 2024.
Foxx reported AbbVie stock holdings in a May 2025 financial filing.
Market Landscape
Legislative efforts to regulate industry standards often face pushback from committee leaders with financial ties to the affected sectors. Foxx's opposition to the federal silica exposure rule follows a broader trend of balancing corporate compliance costs against regulatory oversight.
Residents in North Carolina may experience the real-world consequences of these policy decisions through shifted safety standards at local workplaces. These financial links suggest that industry-specific regulations may face delays or weakened enforcement due to private interests.
The takeaway
Transparency in financial holdings remains a critical component for maintaining trust in legislative oversight committees. Investors and voters should monitor how personal portfolios align with the regulatory agendas of elected officials.
Further reading
For additional context on corporate influence in policy, explore our Public Companies section.
Source note: This article includes information reported by The Daily Caller.
Live Poll
Should members of Congress be prohibited from owning stocks in industries they regulate?
